Thymmune Therapeutics Email Format

Biotechnology ResearchMassachusetts, United States11-50 Employees

Thymmune Therapeutics is a biotechnology research company based in Cambridge, Massachusetts, developing a machine learning–driven thymic cell engineering platform to restore normal immune function in aging and disease. The company leverages iPSC-thymic cell manufacturing to produce off-the-shelf cells at scale. It is pursuing a pipeline of therapies to treat immunodeficiencies, transplant-related conditions, and autoimmune diseases. Thymmune has 11–50 employees and is located at 238 Main Street, Cambridge, MA 02142. Public disclosures indicate financing activity in 2023, including seed funding and subsequent investments; more information is available at thymmune.com.

Sign up for free to view info

Company overview Employee directory